Clinical Trials Browser

Phase 2 × Neurilemmoma × CNS × Clear all

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT02988726 2017-07-26

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

Phase 2 Terminated

3 enrolled

CNS

Neurilemmoma, Neurofibroma, Central Nervous System Neoplasms

NCT00973739 2016-03-22

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase 2 Completed

21 enrolled 8 charts

CNS

Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

Clinical Trials

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors